Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO

Annual Depreciation & Amortization Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
274 K	192 K	127 K	45 K	35 K	14 K	15 K	603 K	641 K	725 K	938 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
938 K	14 K	328 K

Quarterly Depreciation & Amortization Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	322 K	198 K	114 K	-	167 K	75 K	37 K	-	119 K	77 K	39 K	-	89 K	50 K	11 K	-	33 K	22 K	53 K	-	23 K	13 K	5 K	-	11 K	7 K	4 K	30 K	211 K	164 K	-	102 K	462 K	310 K	102 K	156 K	484 K	326 K	156 K	167 K	555 K	382 K	167 K	194 K	732 K	502 K	194 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
732 K	4 K	172 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Adagene ADAG	723 K	$ 2.62	28.82 %	$ 147 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 25.92	-0.86 %	$ 1.26 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
BioXcel Therapeutics BTAI	309 K	$ 1.84	1.66 %	$ 4.66 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.66	-1.85 %	$ 16.7 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 67.49	-3.02 %	$ 9.03 B	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.51	8.41 %	$ 9.81 B	Israel
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	3.2 M	$ 2.04	28.3 %	$ 192 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	673 M	$ 171.89	-1.1 %	$ 25 B	USA
Bio-Path Holdings BPTH	82 K	-	-	$ 100 K	USA
BioVie BIVI	229 K	$ 1.2	-3.7 %	$ 1.77 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Corcept Therapeutics Incorporated CORT	795 K	$ 44.32	7.3 %	$ 4.58 B	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA